Skip to content

#inhibition

4 public questions tagged with this topic.

PLC-gamma inhibition circumvented by:

Fertilization calcium signaling requires phospholipase C-gamma to generate second messenger IP3 that opens ER calcium channels. Upon Src tyrosine kinase activation at sperm entry site, PLC-gamma hydrolyzes PIP2 producing IP3 binding ER receptors releasing calcium globally as wave. If PLC-gamma inhibited pharmacologically with U73122 inhibitor, calcium wave fails and cortical granule exocytosis and activation do not occur. Direct microinjection of IP3 downstream restores calcium release even when PLC blocked, because IP3 directly opens ER channels bypassing lipid hydrolysis step. Calcium injection also triggers release but less faithfully. ATP and Bindin cannot substitute.

Ref: Gilbert, Developmental Biology, 12th ed., Chapter 7: PLC-gamma inhibition rescued by IP3 microinjection calcium release.

Organizer-induced neural tissue formation involves inhibition of:

Ectodermal competence model proposes both neural and epidermal fates possible. BMP4 secreted ventrolaterally binds BMPR inducing Smad1/5/8 phosphorylation, activating epidermal genes like keratin and Xvent while repressing neural genes Sox2, Zic1 and FoxD5. Organizer secretes three BMP antagonists chordin, noggin and follistatin that bind BMPs extracellularly preventing signaling. BMP inhibition dorsalizes ectoderm allowing neural transcription factors to dominate, neural plate forms. FGF and Wnt modulation assist but central switch for neural induction is BMP inhibition demonstrated by neuralization after dominant-negative BMP receptor expression. This illustrates conserved developmental logic of morphogen gradients patterning embryonic axes through Wnt and BMP antagonism.

Ref: NCBI Bookshelf, Developmental Biology Gilbert: Neural induction - BMP inhibition by organizer signals.

Sox9 directly inhibits:

Sox9 promotes testis pathway not only by activating male genes but also by antagonizing ovarian Wnt4/β-catenin signaling creating mutually exclusive fates. Sox9 binds and represses promoters of Wnt4 and Foxl2 and interferes with β-catenin transcriptional activity via competition for co-activators and direct protein interaction. This mutual repression creates bistable switch ensuring exclusive adoption of one gonadal identity. In XY gonads high Sox9 blocks Wnt4 preventing Follistatin expression and allowing testis-specific vasculature. Conversely Wnt4/β-catenin represses Sox9 in XX, illustrating reciprocal inhibition essential for sexual dimorphism.

Ref: Nature Reviews Genetics, Sox9 inhibits Wnt4 pathway - mutually antagonistic sex determination.

What happens if Cdc14 phosphatase is inhibited?

When Cdc14 phosphatase activity compromised, consequence is arrest in late anaphase or telophase despite successful cohesin cleavage and initial chromosome segregation. Cdc14 normally released through FEAR and MEN pathways dephosphorylates key CDK substrates: Cdh1 converting APC/C coactivator to Cdh1 isoform leading to degradation of cyclin B, Plk1 and securin remnants, Swi5 transcription factor enabling synthesis of Sic1 stoichiometric CDK inhibitor, Cdc15 reinforcing feedback, and structural proteins Fin1, Ase1, Ask1 promoting spindle stability reversal. Inhibition via genetic deletion, temperature sensitive alleles, siRNA or small molecule blocks those events. Cyclin B and remaining CDK1-Cyclin B complexes persist, mitotic phosphorylations on lamins, condensins, nucleoporins remain high, nuclear envelope fails to reform around segregated masses, chromosomes stay condensed, central spindle poorly organized and actomyosin contraction defective due to persistence of CDK phosphorylation on Iqg1 and Hof1. In animal cells PP2A-B55 partially compensates but combined loss leads to prolonged hyperphosphorylated state, impaired abscission and frequent cytokinesis failure producing binucleate tetraploid daughters predisposing to aneuploidy. Additional feedback loops involving polo-like kinases, phosphatases and SCF-mediated degradation reinforce irreversibility and protect against premature progression that would compromise genome integrity and viability.

Ref: Stegmeier & Amon, Phenotype of Cdc14 Loss and Mitotic Exit Block, Annu Rev Genet 2004; NCBI, Consequences of Cdc14 Inhibition.